Pharmalot… Pharmalittle… The Weekend Nears
1 CommentBy Ed Silverman // January 20th, 2012 // 8:09 am
And so, another working week is about to draw to a close. As you know, this is our signal to daydream about weekend plans. In fact, we already have a list, which includes spending time with our short and not-so-short people, and catching up with some favorite relatives. Oh yes, a few naps are planned, as well. And you? Will you curl up with a good e-book? Make time for someone special? Compare your tax rate with what Mitt pays? Whatever you do, have a grand time. But be safe. See you soon…
AstraZeneca May Pursue Big Deals After Setbacks (Bloomberg News)
Merck Settles Vioxx Lawsuits In Canada For $37 Million (Associated Press)
PhRMA Wants Clearer FDA Rules For Diet And Diabetes Pills (Reuters)
Biotech Funding Hits A Four-Year High (Bloomberg News)
Yaz Lawyers Want Judge To Review FDA Conflicts (Madison County Record)
EMA Issues Guidelines For Biosimilar MS Drugs (Reuters)
Alnylam Cuts One-Third Of Its Workforce (Xconomy)
Kansas Bill Would Allow Exemptions From Vaccinations (Associated Press)
M&A In India May Face Delays (Business Standard)
Fake Pharma Web Sites Promoted Through LinkedIn Spam (SpamFighter)
EDITOR’S NOTE: Please check this post for updates throughout the morning
beagle pix thx to carrera911e on flickr
Observer
Sounds like a grand plan, Ed. The rest of us in north NJ were planning to avoid travel and shovel snow? It will be fun to observe whose plans turn out better…